Numenta
Numenta, founded by Jeff Hawkins, Dileep George, and Donna Dubinsky, is a neuroscience-based AI research company that has operated for over two decades with a focus on understanding the brain's neocortex to build machine intelligence.
Profile
Develops AI algorithms based on neuroscience principles, specifically the Thousand Brains Theory of the neocortex, and licenses them through its parent company Azenta for life sciences applications.
Numenta, founded by Jeff Hawkins, Dileep George, and Donna Dubinsky, is a neuroscience-based AI research company that has operated for over two decades with a focus on understanding the brain's neocortex to build machine intelligence. The company is best known for its Thousand Brains Theory, which posits that the brain uses thousands of complementary models to understand the world. As of 2025, Numenta has spun out its core research into the Thousand Brains Project, a nonprofit open-source initiative that became its own entity on January 1, 2025.
The company itself has not disclosed recent funding rounds or standalone revenue; its financial trajectory is now tied to its parent, Azenta, Inc. (Nasdaq: AZTA), a life sciences tools company that acquired Numenta in 2021. Azenta's most recent earnings (Q2 FY2026, ended March 31, 2026) show revenue of $145 million from continuing operations, down 3% sequentially and flat year-over-year, with an adjusted EBITDA margin of 5.4%. The company revised its full-year FY2026 guidance downward, citing execution gaps and a cautious demand environment in North America, and pushed its long-range plan targets from 2028 to 2029.
Numenta's technology is not a direct product; it is embedded within Azenta's life sciences workflow, particularly in sample management and multiomics. The company's current relevance lies in its attempt to commercialize brain-inspired algorithms for enterprise AI, though it has yet to produce a standalone product or disclose a customer base beyond its parent.
Who buys this
- Life sciences researchers using Azenta's sample management and multiomics platforms
- Academic neuroscience labs studying cortical computation
- Open-source AI developers contributing to the Thousand Brains Project
- Enterprise AI teams evaluating alternative architectures to deep learning
Strengths and what to watch
Strengths
- Foundational neuroscience research with a 20-year track record, including the Thousand Brains Theory, which offers a distinct alternative to statistical deep learning.
- Spin-out of the Thousand Brains Project into an independent nonprofit in January 2025, creating a community-driven open-source ecosystem that reduces corporate dependency.
- Integration into Azenta's life sciences portfolio provides a captive commercial channel and access to recurring revenue from sample management and multiomics customers.
Watch for
- No disclosed standalone revenue or customer base outside parent Azenta; the technology has not produced a commercial product in over 20 years.
- Azenta's recent financial struggles—revenue decline, downward guidance revision, and long-range plan extension to 2029—suggest limited near-term commercial traction for Numenta's technology.
- The Thousand Brains Project's independence may dilute Numenta's control over its core IP and create governance friction between the nonprofit and the for-profit parent.
Recent moves
Key Information
- Industry
- Commercial AI Research
- Founded
- 2005
- Employees
- 23
- Headquarters
- Redwood City, California, United
- Country
- United States
Frequently Asked Questions
What is Numenta and what does it do?
Numenta is a neuroscience-based AI research company founded by Jeff Hawkins. It develops algorithms inspired by the brain's neocortex, specifically the Thousand Brains Theory. As of 2025, its core research has spun out into the independent nonprofit Thousand Brains Project.
What is the Thousand Brains Theory?
The Thousand Brains Theory, developed by Numenta, proposes that the brain uses thousands of complementary models to understand the world. It offers a distinct alternative to statistical deep learning by focusing on how the neocortex processes sensory input and builds knowledge.
Is Numenta a public company or owned by another company?
Numenta is not a standalone public company. It was acquired by Azenta, Inc. in 2021 and is now a subsidiary. Azenta is a publicly traded life sciences tools company (Nasdaq: AZTA) that embeds Numenta's technology into its sample management and multiomics platforms.
Has Numenta released any commercial products?
Numenta has not released a standalone commercial product in over 20 years. Its technology is embedded within Azenta's life sciences workflow, particularly in sample management and multiomics. The company has not disclosed a customer base outside its parent or standalone revenue.
What is the Thousand Brains Project and why was it spun out?
The Thousand Brains Project is an independent nonprofit open-source initiative launched on January 1, 2025. It was spun out from Numenta to create a community-driven ecosystem for brain-inspired AI research, reducing corporate dependency and fostering broader collaboration among developers and researchers.
How is Azenta's financial performance affecting Numenta?
Azenta's recent financial results show revenue decline and downward guidance revisions. In Q2 FY2026, revenue was $145 million, down 3% sequentially. The company extended its long-range plan to 2029, suggesting limited near-term commercial traction for Numenta's technology within the parent.
Sources
- www.numenta.com — Company description, Thousand Brains Project spin-out, mission statement
- investors.azenta.com — Azenta Q1 FY2026 revenue ($149M), organic growth decline, management commentary
- www.prnewswire.com — Azenta Q2 FY2026 revenue ($145M), FY2026 guidance revision to ~$603-621M, long-range plan extension to 2029
- thousandbrains.org — Thousand Brains Project as independent nonprofit entity (referenced from numenta.com)